Featured Patent Studies
GEN 415
Exp: 03/31/10
HEALTHCARE - PHARMACEUTICAL
METHODS OF PRODUCING IMMUNOGLOBULINS
This patent relates to methods for producing an immunoglobulin, and to the vectors used to produce immunoglobulins or fragments, and to cells transformed with the vectors.
ACTIVE
  $30,000.00
 
PUB 122
Exp: 03/12/10
TECHNOLOGY - PUBLICATION
BUYER WORKSTATION MANUAL
This Study is a request for a specific publication. The Reward will be paid for the first complete copy.
ACTIVE
  $10,000.00
 
AUTO 442
Exp: 01/30/10
TECHNOLOGY - AUTOMOTIVE
METHOD FOR STOPPING AND STARTING AN ENGINE
The technology involves stop/start systems for motor vehicle combustion engines.
PENDING REVIEW
  $15,000.00
 
AUTO 655
Exp: 01/30/10
TECHNOLOGY - AUTOMOTIVE
AUTOMOBILE WITH STOP/START SYSTEM
The patent relates to motor vehicles having an internal combustion engine and a system to automatically stop and start the internal combustion engine.
PENDING REVIEW
  $15,000.00
 
MED 081
Exp: 01/15/10
HEALTHCARE - MEDICAL & SURGICAL DEVICES
NEGATIVE PRESSURE WOUND THERAPY
The patents relate to negative pressure wound therapy.
PENDING REVIEW
  $25,000.00
 
WG 164
Exp: 01/04/10
TECHNOLOGY - SOFTWARE
FACEBOOK DEFENSE - MANAGING ONLINE NETWORK MEMBER RELATIONSHIPS
The patent claims methods and systems for identifying and managing relationships formed between members of an online network, aka social networks.
PENDING REVIEW
  $20,000.00
 
BMS 911
Exp: 01/04/10
HEALTHCARE - PHARMACEUTICAL
REYATAZ - BRISTOL-MYERS
These patents cover the drug REYATAZ. It is used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS).
PENDING REVIEW
  $20,000.00
 
TR 389
Exp: 11/02/09
TECHNOLOGY - SOFTWARE
TWITTER DEFENSE: DIGITAL NOTIFICATION AND RESPONSE SYSTEM
These patents relate to a system and methods for digital notifications and receiving responses.
PENDING REVIEW
  $15,000.00
 
BAYRY-178
Exp: 11/02/09
HEALTHCARE - PHARMACEUTICAL
LEVITRA - BAYER
This patent relates to 2-phenyl-substituted imidazotriazinones and to their use as pharmaceuticals, in particular in the treatment of erectile dysfunction.
PENDING REVIEW
  $15,000.00
 
WCRX 161
Exp: 08/15/09
HEALTHCARE - PHARMACEUTICAL
DORYX - WARNER CHILCOTT, MAYNE
The active ingredient in Doryx is the antibiotic doxycycline hyclate. It is used for the treatment of acne. The patent claims are directed to the types of materials used to coat the medication for administering to patients.
PENDING REVIEW
  $15,000.00
 
DISCA 851
Exp: 08/15/09
TECHNOLOGY - SOFTWARE
ELECTRONIC BOOK SECURITY AND COPYRIGHT PROTECTION SYSTEM
This patent relates to the offering, encryption and distribution of electronic books.
PENDING REVIEW
  $15,000.00
 
WYE 814
Exp: 08/15/09
HEALTHCARE - PHARMACEUTICAL
HORMONAL CONTRACEPTION
This patent relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen.
PENDING REVIEW
  $15,000.00
 
SQNM 076
Exp: 06/15/09
HEALTHCARE - MEDICAL DIAGNOSTICS
SEQUENOM'S INFECTIOUS AGENT IDENTIFICATION
The patents relate to identifying infectious diseases. IBIS Biosciences, accused of infringement, has as customers the Departments of Defense and Homeland Security, and the CDC.
PENDING REVIEW
  $25,000.00
 
EMER 911
Exp: 04/15/09
TECHNOLOGY - WIRELESS COMMUNICATION
EMER 911 LOCATION DETECTION FOR MOBILE PHONES
The is a study of four patents related to emergency 911 processing based on the precise location of a mobile phone user.
PENDING REVIEW
  $50,000.00
 
SONY 560
Exp: 03/31/09
TECHNOLOGY - HOUSEHOLD AUDIO/VIDEO
BLU-RAY DISC DRIVES TECHNOLOGY
The patent relates Blu-Ray Disc drives in the Sony PlayStation 3 video game system including a Bl-Ray Disc drive.
PENDING REVIEW
  $50,000.00
 
Information on Article One does not constitute patent law, investment, securities or trading advice.

Full List Patent Study Results Technology Healthcare

Public Interest AOP Community Profit Sharing Suggest a Study Respond to a Study

Categories

Industry Sectors

Expiration Date



© 2010 ARTICLE ONE PARTNERS, ALL RIGHTS RESERVED
ABOUT AOP  |  TOUR AOP  |  TEAM AOP  |  FAQS  |  PRESS  |  CONTACT US  |  CAREERS  |  LEGAL  |  PRIVACY POLICY